Fluidigm Mass Cytometry Videos

Interrogating CAR T cell spatiotemporal plasticity | Lior Goldberg, MD

Speaker:
Lior Goldberg, MD
Pediatric Oncologist, Physician-Scientist, City of Hope Comprehensive Cancer Center

Embed

Embed Player

Inline Embed
Lightbox Embed

<script type='text/javascript' async src='https://play.vidyard.com/embed/v4.js' data-playbackurl='play.vidyard.com'></script><img style='margin: auto; display: block; width: 100%; 'class='vidyard-player-embed' src='https://play.vidyard.com/NFe85HmvgBubs2sxVy2nJR.jpg' data-height='540' data-width='960' data-width='auto' data-controller='hubs' data-action='show' data-uuid='NFe85HmvgBubs2sxVy2nJR' data-type='inline' />

<script type='text/javascript' async src='https://play.vidyard.com/embed/v4.js' data-playbackurl='play.vidyard.com'></script><img style='margin: auto; display: block; width: 100%; 'class='vidyard-player-embed' src='https://play.vidyard.com/NFe85HmvgBubs2sxVy2nJR.jpg' data-height='540' data-width='960' data-width='auto' data-controller='hubs' data-action='show' data-uuid='NFe85HmvgBubs2sxVy2nJR' data-type='lightbox' />

Choose your embed type above, then paste the code on your website.

Related Videos

Feb-16-2022

Speaker: Matthew Spitzer, PhD Assistant Professor, University of California San Francisco (UCSF)

Understanding metabolic dynamics of T cells and CAR T cells from single-cell data | Matthew Spitzer

Feb-16-2022

Speaker: Jonathan Caron, PhD Researcher, Assistance Publique – Hôpitaux de Paris

Mass cytometry: A robust platform for the comprehensive immunomonitoring of CAR T cell therapies

Feb-16-2022

Speaker: Greg Hopkins Associate Manager, Scientist, 2seventy bio

Expanding CAR T cell profiling to accelerate therapeutic insights | Greg Hopkins

May-20-2022

Roe shares her approach to high-parameter immune monitoring panel design, as well as the planning and exe...

Cutting Edge Cytometry and Clinical Trials: A Case Study | Caroline Roe, MLI

May-20-2022

Vemula details the validation process for two Maxpar panels offered by Labcorp: the Maxpar Direct Immune ...

Method validation studies using the Maxpar® Direct™ Immune Profiling Assay™ | Sasidhar Vemula, PhD

May-19-2022

Motta describes how fully automated flow cytometry with CyTOF XT™ combined with the deep immune profiling...

Efficient, High-Content Immune Profiling with CyTOF® XT and MDIPA | Vinicius Motta, PhD

Apr-04-2022

Speakers: Katie Vowell, PhD , Principal Investigator – Immunology, GlaxoSmithKline Florence Perrin Patel...

Single-Cell Immune Profiling Can Help Resolve Tumor Microenvironment Complexities | GEN

Feb-16-2022

Emily Thrash, Field Application Scientist for Mass Cytometry at Fluidigm, introduces CyTOF® XT, the most ...

Introducing CyTOF® XT and Maxpar™ Direct™ Assays for efficient high-content immune profiling

Feb-08-2022

Petter Brodin, MD, PhD, discusses how he is implementing the new, high-throughput CyTOF® XT high-dimensio...

Mass Cytometry for Precision Medicine | Petter Brodin, MD, PhD

Nov-10-2021

Long-term tracking of vaccine-elicited tumor antigen-specific T cell responses in cancer patients using C...

Leveraging CyTOF to track cancer vaccine induced T cell responses for up to 20 years | Erika Crosby

Nov-05-2021

Part of our Scientist in the Spotlight series: Date: 8 December, 2020 To understand why a particular imm...

Profiling three layers of human immunity with CyTOF®, Olink® and automated RNA-seq

Oct-26-2021

In 2017, the NCI established four Cancer Immune Monitoring and Analysis Centers (CIMACs), which perform s...

CyTOF in the Cancer Immune Monitoring and Analysis Centers (CIMAC) | Holden Maecker, PhD